Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis

Osteoporosis is characterized by decreased bone mineral density and increased risk of fracture. Raloxifene is one of the treatments of osteoporosis. However, the responses were variable among patients. Previous studies revealed that the genetic variants are involved in the regulation of treatment ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Hsing-Fang, Chou, Po-Hsin, Lin, Gan-Hong, Chou, Wan-Hsuan, Wang, Shih-Tien, Adikusuma, Wirawan, Mugiyanto, Eko, Hung, Kuo-Sheng, Chang, Wei-Chiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479487/
https://www.ncbi.nlm.nih.gov/pubmed/32934756
http://dx.doi.org/10.1155/2020/8855423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479487/
https://www.ncbi.nlm.nih.gov/pubmed/32934756
http://dx.doi.org/10.1155/2020/8855423

Ejemplares similares